Previous 10 | Next 10 |
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2020. Recent H...
Outset Medical's IPO unlock happens on 3/15, where 27.3 million more shares become available for sale, roughly twice the current float. Revenue expectations for the Q4 quarter may be too high and could show negative sequential growth. Despite a reasonable $35 million/year run rate...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2020 after...
Healthcare Industry Veteran Brings Digital Health Expertise and Consumer-Centric Approach to Furthering Company’s Mission of Transforming Dialysis Treatment Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first...
In this episode of Industry Focus: Wildcard , Dylan Lewis and Motley Fool contributor Brian Feroldi do a deep dive into Outset Medical (NASDAQ: OM) , a dialysis system developer which recently came public. They discuss how Outset's system works, its advantages over tradition...
Chase Coleman’s 13F portfolio value increased from $25.79B to $35.53B this quarter. Tiger Global increased Pinduoduo and CrowdStrike Holdings during the quarter. The largest three positions are JD.com, Microsoft, and Sunrun and they add up to ~25% of the portfolio. Fo...
Outset Medical (OM) has priced its public offering of 4M common shares offered by certain of its stockholders at $53.00/share.Underwriters' over-allotment is an additional 600K shares.Outset will not receive any of the proceeds from the sale of the shares by the selling stockholders. BofA Sec...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the pricing of an underwritten public offering of 4,000,000 shares of its common stock by cer...
Outset Medical (OM) announces the commencement of proposed public offering of 4M common shares. Underwriters' over-allotment option includes the purchase of additional 600K shares. Price, size and other terms not yet determined.Stock -3% AH. For further details see: Outse...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the commencement of a proposed underwritten public offering of 4,000,000 shares of its common...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...